Executive Insights

We chatted with Gary Justak, President of Enovis’ Foot and Ankle business, about R&D focus, managing integrations and long-term goals....

Selected quotes by orthopedic executives about the market's dynamics and performance in the second quarter of 2023....

Dr. Stephen O’Connell helped open the Eisenhower Desert Orthopedic Center to capitalize on the migration of cases to the outpatient...

Exactech's Chief Strategy Officer and Chief Medical Officer takes his insight on hip resurfacing from the operating room to the...

We asked three orthopedic CEOs about the opportunities and challenges in the orthopedic enabling technology space....

Ron Sacher recognized a need for a better solution to treat patients with spinal stenosis and degenerative spondylolisthesis....

Through 1Q23, the orthopedic market enjoyed significant growth due to improving procedure volumes, reduced headwinds and weaker comparisons....

We spoke to Enovis CEO Matt Trerotola about foundational implant technologies, ASC penetration, tech adoption and successful M&A deals....

Ortho execs on enabling technology’s important role in implant sales, recent M&A deals that worked and improving surgical procedure volumes....

Nanochon is targeting a $2 billion market in the U.S. with its Chondrograft implant for cartilage repair and replacement....